Interview with Michael Pehl, Managing Director, Celgene Germany
Celgene is very new in the German market. What would you say have been the main achievements of Celgene Germany since its establishment in 2006? Celgene Germany started as a…
Address: Albert-Ludwig-Grimm-Straße 20
69469 Weinheim ,Germany
Tel: +49 6201/ 2598 0
Web: http://www.cytonet.de/en/
The Cytonet Group is active in the field of medical biotechnology. It develops, produces and markets new, cell-based, medicinal products. Cytonet partners include internationally leading university hospitals. Their basic research is carried over into internal procedural approaches and promising technologies with the aim of developing pioneering products as a result. Today, Cytonet is Germany’s largest cell therapy enterprise.
Celgene is very new in the German market. What would you say have been the main achievements of Celgene Germany since its establishment in 2006? Celgene Germany started as a…
Could you briefly present the Association of German Biotechnology Companies (VBU) and DECHEMA e.V. to our readers and describe their importance to the German biotechnology industry? VBU is a non…
Hospira, which was spun-off from Abbott Laboratories in 2004, is a global specialty pharmaceutical and medication delivery company driven by its vision of Advancing Wellness™. Bringing proven leadership and experience,…
How challenging is for you as General Manager of Nycomed Germany to lead the number one subsidiary of the Nycomed Group and what would you highlight as the key milestones…
The acquisition of IVAX in 2006 was decisive to establish Teva as the number one generic producer worldwide and further consolidate the company in the German market; and this process…
See our Cookie Privacy Policy Here
